Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Del Nido vs HTK Cardioplegia in Aortic Valve Replacement
NCT06235424Phase 4Active, not recruiting
- Sponsor
- Medical University of Gdańsk
- Start
- Oct 2018
- Primary completion
- Apr 2023
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of del Nido cardioplegia in cardiac ischemia (2 arms), sponsored by Medical University of Gdańsk. Primary endpoints: Creatine Kinase-MB at 48 hours and High-Sensitivity Troponin I at 48 hours. Started Oct 2018; status: active, not recruiting.
02
Drugs
del Nido cardioplegia
03
Conditions
cardiac ischemia
Beyond the preview
Go deeper on NCT06235424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06235424.